会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 인간 파스 단백질에 결합하는 파스연결인자에 대한 단일클론항체와 이를 생산하는 융합세포주
    • 针对人类FAS相关因子1(HFAF1)的单克隆抗体及其生产的杂交瘤
    • KR1020040059246A
    • 2004-07-05
    • KR1020020085833
    • 2002-12-28
    • 한국생명공학연구원
    • 임종석김은희이희구이공주채순기김효선하경수류승욱김광동
    • C07K16/18
    • C07K16/18C12N5/163
    • PURPOSE: Monoclonal antibodies against human Fas-associated factor 1 (hFAF1) and hybridomas producing the same are provided, thereby specifically detecting FAF1 protein and inducing immunoprecipitation of hFAF1, so that they can be used in quantification of cell death-associated proteins including Fas protein and verification of association of these proteins to cell death diseases. CONSTITUTION: The monoclonal antibodies against human Fas-associated factor 1 (hFAF1) are derived from mouse, and produced from hybridomas FAF-85(KCTC 10366BP) and FAF-99(KCTC 10367BP). A method for producing the hybridomas producing the monoclonal antibodies against human Fas-associated factor 1 (hFAF1) comprises the steps of: immunizing a mouse with a GST(Glutathion-S-transferase) fusion protein of human Fas-associated factor 1 (hFAF1); fusing spleen cells of the immunized mouse with myeloma cell; and culturing the fusion cells to produce the monoclonal antibodies against human Fas-associated factor 1 (hFAF1). The method for diagnosis of cell death-associated diseases comprises measuring the expression level of human Fas-associated factor 1 (hFAF1) using the monoclonal antibodies against human Fas-associated factor 1 (hFAF1) produced from hybridomas FAF-85(KCTC 10366BP) or FAF-99(KCTC 10367BP).
    • 目的:提供针对人Fas相关因子1(hFAF1)和产生其的杂交瘤的单克隆抗体,从而特异性检测FAF1蛋白并诱导hFAF1的免疫沉淀,使其可用于定量细胞死亡相关蛋白(包括Fas蛋白) 并验证这些蛋白质与细胞死亡疾病的关联。 构成:针对人Fas相关因子1(hFAF1)的单克隆抗体来自小鼠,由杂交瘤FAF-85(KCTC 10366BP)和FAF-99(KCTC 10367BP)产生。 制备产生针对人Fas相关因子1(hFAF1)的单克隆抗体的杂交瘤的方法包括以下步骤:用人Fas相关因子1(hFAF1)的GST(谷胱甘肽-S-转移酶)融合蛋白免疫小鼠, ; 将免疫小鼠的脾细胞与骨髓瘤细胞融合; 并培养融合细胞以产生针对人Fas相关因子1(hFAF1)的单克隆抗体。 用于诊断细胞死亡相关疾病的方法包括使用针对由杂交瘤FAF-85(KCTC 10366BP)产生的人Fas相关因子1(hFAF1)的单克隆抗体或人类Fas相关因子1(hFAF1)的表达水平或 FAF-99(KCTC 10367BP)。